Director at Clarus (CLAR) granted 20,000 stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Clarus Corp director Nicolas Sokolow received a grant of stock options covering 20,000 shares of common stock. The options have an exercise price of $3.11 per share and expire on May 28, 2036. They were granted under Clarus’ Amended and Restated 2015 Stock Incentive Plan.
The award vests in four equal installments of 5,000 options on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027. Following this grant, Sokolow holds options to purchase 20,000 shares directly. This is a compensation-related grant rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
SOKOLOW NICOLAS
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to purchase) | 20,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to purchase) — 20,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Stock options granted: 20,000 options
Exercise price: $3.11 per share
Options after transaction: 20,000 options
+5 more
8 metrics
Stock options granted
20,000 options
Grant to director Nicolas Sokolow on May 28, 2026
Exercise price
$3.11 per share
Exercise price for Sokolow’s stock options
Options after transaction
20,000 options
Total options held directly following the grant
Expiration date
May 28, 2036
Option expiration for the 20,000-share grant
First vesting tranche
5,000 options
Vest and become exercisable on June 30, 2026
Second vesting tranche
5,000 options
Vest and become exercisable on September 30, 2026
Third vesting tranche
5,000 options
Vest and become exercisable on December 31, 2026
Fourth vesting tranche
5,000 options
Vest and become exercisable on March 31, 2027
Key Terms
Stock Option (right to purchase), Amended and Restated 2015 Stock Incentive Plan, Common Stock, vest and become exercisable
4 terms
Stock Option (right to purchase) financial
"security_title: Stock Option (right to purchase)"
Amended and Restated 2015 Stock Incentive Plan financial
"was granted under the Issuer's Amended and Restated 2015 Stock Incentive Plan"
Common Stock financial
"Issuer's common stock, $0.0001 par value per share (the "Common Stock")"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
vest and become exercisable financial
"Options to purchase 5,000 shares ... will vest and become exercisable on each date"
FAQ
What did Clarus (CLAR) disclose about director Nicolas Sokolow in this Form 4?
Clarus disclosed that director Nicolas Sokolow received a grant of stock options covering 20,000 shares of common stock. These options were issued as a compensation-related award under the company’s Amended and Restated 2015 Stock Incentive Plan, not through open-market trading.
What is the exercise price and expiration date of the Clarus (CLAR) options granted to Nicolas Sokolow?
The options granted to Nicolas Sokolow have an exercise price of $3.11 per share and expire on May 28, 2036. This means he may choose to purchase Clarus common stock at $3.11 before that expiration date, subject to the vesting schedule.
How do the Clarus (CLAR) stock options granted to Nicolas Sokolow vest over time?
The 20,000 Clarus stock options vest in four equal installments of 5,000 options. Vesting dates are June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, meaning portions of the award become exercisable on each of those dates.
Under which plan were the Clarus (CLAR) stock options for Nicolas Sokolow granted?
The options were granted under Clarus Corporation’s Amended and Restated 2015 Stock Incentive Plan. This plan provides equity-based compensation awards, such as stock options, to directors and other eligible participants, aligning their interests with shareholders over the long term.